-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on Coherus Biosciences (CHRS)
-
-
-
-
-
-
-
Coherus Oncology names Arvind Sood as chief strategy officer
-
-
-
-
-
-
-
H.C. Wainwright Upgrades Coherus Biosciences (CHRS) to Buy
-
-
-
-
-
-
-
TD Cowen Reiterates Buy Rating on Coherus Biosciences (CHRS)
-
-
-
-
-
467,659 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

